IFCG partners with MEDEZE, a leading company in stem cells and advanced technology.

Dr. Veerapol Khemarangsan (2nd from left), Chief Executive Officer, and Ms. Danita Phitaknetikul (1st from left), Chief Business Development Officer of Medeze Group Public Company Limited ("MEDEZE"), together with Mr. Withoon Lertpanomwan (2nd from right), Chief Executive Officer, and Mr. Thak Phanwatanasing (1st from right), Chief Distribution Officer of IFCG Public Company Limited ("IFCG"), signed a memorandum of understanding (MOU) between Medeze Group Public Company Limited and IFCG Public Company Limited.

Through this partnership, MEDEZE is expanding its network by adding over 400 representatives to provide consultations and offer services related to the storage, analysis, and cultivation of stem cells derived from umbilical cord blood, adult adipose tissue, and hair follicle cells. The collaboration also aims to reach IFCG’s high-net-worth customer base of over 50,000 individuals. The signing ceremony took place at IFCG Public Company Limited, 26th floor, Amigo Tower.